Nurses are part of the Antimicrobial Stewardship Team
Nurses are part of the Antimicrobial Stewardship Team
Active engagement of nurses in antimicrobial stewardship activities is long-overdue. We can all appreciate the nursing presence in management of antimicrobials in different clinical settings, however there is little to no evidence that supports nurses as antimicrobial stewards. This is partly due to barriers, and knowledge gaps that currently exist in nursing practice. We have created nursing resources to help address some of the knowledge gaps that currently exist.
Active engagement of nurses in antimicrobial stewardship activities is long-overdue. We can all appreciate the nursing presence in management of antimicrobials in different clinical settings, however there is little to no evidence that supports nurses as antimicrobial stewards. This is partly due to barriers, and knowledge gaps that currently exist in nursing practice. We have created nursing resources to help address some of the knowledge gaps that currently exist.
Tackling AMR in Canada:
It Takes A Village
25 November, 2022, 12:00 EST
Objectives:
-
Become familiar with the most recent surveillance data on antimicrobial resistance and use.
-
Understand the roles and responsibilities of the newly formed Antimicrobial Resistance Task Force of the Public Health Agency of Canada.
-
Review the strategic priorities of the AMR Task Force, and ongoing actions to prevent and mitigate AMR and improve appropriate AMU.
Dr. Don Sheppard
MD, FRCPC, FECMM, FAAM, FASCI, FCAHS.
Dr. Sheppard currently serves as the Executive Scientific Director of the Antimicrobial Resistance Task Force of the Public Health Agency of Canada. A clinician-scientist and professor in Medicine and Microbiology & Immunology at McGill University, he practices medical microbiology at the McGill University Health Centre.
Dr. Sheppard’s research interests focus on elucidating the mechanisms by which biofilm-forming microorganisms cause human disease and resist antimicrobial therapy in order to develop new therapeutics for these infections. He has published over 150 research papers and book chapters and has delivered over 200 invited lectures worldwide.
Dr. Sheppard has been the recipient of numerous awards including a Clinician-Scientist award from the Canadian Institutes of Health Research and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. He is an elected fellow of the American Society of Clinical Investigation and the American Academy of Microbiology.